TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05856370: The Ailliance Post-Market Clinical Study

Sponsor: Medtronic Spinal and Biologics · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 1000 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$7,337,200

Rescue Site Savings

+$4,847,200

Unlock Full NCT05856370 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05856370 Rescue Dossier →